Role of heme oxygenase-1 in cardiovascular function

Current Pharmaceutical Design

Volumn 9, Issue 30, 2003, Pages 2479-2487

  Perrella, Mark A ^a,b   Yet, Shaw Fang ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Cytoprotection; Endotoxemia; Hypertension; Hypotension; Ischemia reperfusion; Renovascular; Vein graft stenosis

Indexed keywords

ANGIOTENSIN; APOLIPOPROTEIN E; BACTERIUM LIPOPOLYSACCHARIDE; BILIRUBIN; CARBON MONOXIDE; CREATININE; CYCLIC GMP; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; FERRITIN; GUANYLATE CYCLASE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; INTERLEUKIN 1BETA; IRON; MESSENGER RNA; METALLOPORPHYRIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTOPORPHYRIN ZINC;

ACUTE KIDNEY FAILURE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR FUNCTION; CHRONIC DISEASE; CORONARY ARTERY LIGATION; DISEASE MODEL; DISEASE SEVERITY; ENDOTOXEMIA; GENE DELETION; GENE OVEREXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HYPOTENSION; INCIDENCE; KIDNEY SURGERY; MORTALITY; MOUSE; MYOCARDITIS; NONHUMAN; NULL ALLELE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENOVASCULAR HYPERTENSION; REPERFUSION INJURY; REVIEW; STENOSIS; SURGICAL TECHNIQUE; TRANSGENICS; VEIN DISEASE; VEIN GRAFT;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; MEMBRANE PROTEINS;

EID: 0141919542     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033453776     Document Type: Review

References (75)

1. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968; 61: 748-55.
2. Maines MD. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988; 2: 2557-68.
3. Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 1988; 20: 543-58.
4. Marks GS, Brien JF, Nakatsu K, McLaughlin, BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci 1991; 12: 185-8.
5. Choi AMK, Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15: 9-19.
6. Abraham NG, Drummond GS, Lutton JD, Kappas A. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 1996; 6: 129-68.
7. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-54.
8. McCoubrey WKJ, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 1997; 247: 725-32.
9. Otterbein LE, Choi AMK. Heme oxygenase: Colors of defense against cellular stress. Am J Physiol 2000; 279: L1029-37.
10. Ryter SW, Otterbein LE, Morse D, Choi AMK. Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance. Mol Cell Biochem 2002, 234/235: 249-63.
11. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-6.
12. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989; 243: 388-90.
13. Escalante B, Sacerdoti D, Davidian MM, Laniado-Schwartzman M, McGiff JC. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 1991; 17: 776-9.
14. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin invest 1990; 86: 213-9.
15. Martasek P, Schwartzman ML, Goodman AI, Solangi KB, Levere RD, Abraham NG. Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J Am Soc Nephrol 1991; 2: 1078-84.
16. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol 1996; 271: H1132-8.
17. Christou H, Morita T, Hsieh C.-M, Koike H, Arkonac B, Perrella MA, et al. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000; 86: 1224-9.
18. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 1995; 25: 166-9.
19. Sylvester JT, McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res 1978; 43: 429-37.
20. McGrath JJ, Smith DL. Response of rat coronary circulation to carbon monoxide and nitrogen hypoxia. Proc Soc Exp Biol Med 1984; 177: 132-6.
21. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92: 1475-9.
22. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 1995; 91: 2306-9.
23. Wang R, Wu L, Wang Z. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 1997; 434: 285-91.
24. Kaide JI, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107: 1163-71.
25. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995; 96: 2676-82.
26. Ishizaka N, De Leon H, Laursen JB, Fukui T, Wilcox JN, De Keulenaer F, et al. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 1997; 96: 1923-9.
27. Haugen EN, Croatt AJ, Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 2000; 58: 144-52.
28. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, et al. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: Possible role in renoprotection. Hypertension 2000; 35: 800-6.
29. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, Schwartzman M, et al. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001; 38: 210-5.
30. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94: 10925-30.
31. Yet S-F, Perrella MA, Layne MD, Hsieh C-M, Maemura K, Kobzik L, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999; 103: R23-9.
32. Imai T, Morita T, Shindo T, Nagai R, Yazaki Y, Kurihara H, et al. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res 2001; 89: 55-62.
33. Wiesel P, Patel AP, Carvajal IM, Wang ZY, Pellacani A, Maemura K, et al. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 2001; 88: 1088-94.
34. Goldblatt H, Lynch J, Hanzal RF, Summerville, WW. Studies on experimental hypertension: Production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59: 347-79.
35. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 1997; 29: 1025-30.
36. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997; 272: 32804-9.
37. Ross R. Atherosclerosis - an inflammatory disease, N Engl J Med 1999; 340: 115-26.
38. Wang L-J, Lee T-S, Lee F-Y, Pai R-C, Chau L-Y. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998; 152: 711-20.
39. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997; 100: 1209-16.
40. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signaling pathway in atherosclerosis: Anti-atherogeni actions of bilirubin and carbon monoxide. Cardiovasc. Res 1999; 41: 385-94.
41. Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe H, Maruyama Y, et al. Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Cir Res 2001; 88: 506-12.
42. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Cirulation 2001; 104: 1519-25.
43. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, et al. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001; 104: 1831-6.
44. Grundemar L, Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 1997; 18: 193-5.
45. Yet S-F, Layne MD, Liu X, Chen Y-H, Ith B, Sibinga NES, et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 2003; 10.1096/fj.030187fje.
46. Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, et al. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J 2001; 10.1096/fj.10010017fje.
47. Shi C, Patel A, Zhang D, Wang H, Carmeliet P, Reed GL, et al. Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. Circ Res 1999; 84: 883-90.
48. Duckers HJ, Boehm M, True AL, Yet S-F, San H, Park JL, et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001; 7: 693-8.
49. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001; 8: 433-40.
50. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002; 111: 1-8.
51. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457-69.
52. Bone RC, Grodzin CJ, Balk RA. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235-43.
53. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-7.
54. Yet S-F, Pellacani A, Patterson C, Tan L, Folta SC, Foster L, et al. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem 1997; 272: 4295-301.
55. Pellacani A, Wiesel P, Sharma A, Foster LC, Huggins GS, Yet S-F, et al. Induction of heme oxygenase-1 during endotoxemia is downregulated by transforming growth factor-β1. Circ Res 1998; 83: 396-403.
56. Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 2000; 102: 3015-22.
57. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
58. Yet S-F, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001; 89: 168-73.
59. Vulapalli SR, Chen Z, Chua BH, Wang T, Liang CS. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol 2002; 283: H688-94.
60. Foresti R, Sarathchandra P, Clark JE, Green CJ, Motterlini R. Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: A link to apoptosis. Biochem J 1999; 339: 729-36.
61. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001; 87: 1196-200.
62. Greabu M, Olinescu R, Kummerow FA, Crocnan DO. The levels of bilirubin may be related to an inflammatory condition in patients with coronary heart disease. Acta Pol Pharm 2001; 58: 225-31.
63. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol 2000; 278: H643-51.
64. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001; 166: 4185-94.
65. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, et al. Ferritin: A cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992; 267: 18148-53.
66. Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 1999; 31: 335-40.
67. Pataki T, Bak I, Csonka C, Kovacs P, Varga E, Blasig IE, et al. Regulation of ventricular fibrillation by heme oxygenase in ischemic/reperfused hearts. Antioxid Redox Signal 2001; 3: 125-34.
68. Bak I, Papp G, Turoczi T, Varga E, Szendrei L, Vecsernyes M, et al. The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med 2002; 33: 639-48.
69. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, et al. Gene therapy strategy for long-term myocardial protection using adeno- associated virus-mediated delivery of heme oxygenase gene. Circulation 2002; 105: 602-7.
70. Panahian N, Yoshiura M, Maines MD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. Neurochem 1999; 72: 1187-203.
71. Liu H, Song D, Lee SS. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol 2001; 280: G68-74.
72. Seki T, Naruse M, Naruse K, Yoshimoto T, Tanabe A, Seki M, et al. Induction of heme oxygenase produces load-independent cardioprotective effects in hypertensive rats. Life Sci 1999; 65: 1077-86.
73. Caradonna L, Mastronardi ML, Magrone T, Cozzolongo R, Cuppone R, Manghisi OG, et al. Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Design 2002; 8(11): 995-1005.
74. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharm Design 2002; 8(3): 155-66.
75. Motilva V, Cabeza J, Alarcon de la Lastra C. New issues about melatonin and its effects on the digestive system. Curr Pharm Design 2001; 7(10): 909-31.